Stryker (SYK) Change in Receivables (2009 - 2026)
Stryker (SYK) reported Change in Receivables of -$444.0 million for Q1 2026, down 208.33% year-over-year from $409.8 million in Q1 2025, and down 211.84% quarter-over-quarter from $397.0 million in Q4 2025.
Stryker (SYK) Change in Receivables (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Change in Receivables data on file, last reported at -$444.0 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$444.0 million, down 208.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$427.0 million (down 198.16% YoY), and the FY2025 annual result was -$127.0 million, down 139.56% from the prior year.
- Change in Receivables retreated to -$444.0 million in Q1 2026 per SYK's latest filing, from $397.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $441.0 million in Q4 2023 and troughed at -$444.0 million in Q1 2026.
- A 5-year average of $29.6 million and a median of $36.0 million in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables soared 171.93% in 2024, then tumbled 841.67% in 2025.
- A 5-year view of Change in Receivables shows it stood at $393.0 million in 2022, then increased by 12.21% to $441.0 million in 2023, then retreated by 12.02% to $388.0 million in 2024, then gained by 2.32% to $397.0 million in 2025, then plunged by 211.84% to -$444.0 million in 2026.
- Business Quant data shows SYK's Change in Receivables at -$444.0 million in Q1 2026, $397.0 million in Q4 2025, and -$267.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -14.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -444.00 Mn |
| Mar 31, 2026 | -444.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Dec 31, 2025 | 397.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Sep 30, 2025 | -267.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Jun 30, 2025 | -113.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Mar 31, 2025 | -144.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Dec 31, 2024 | 388.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Jun 30, 2024 | 155.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Mar 31, 2024 | -258.00 Mn |
| Dec 31, 2023 | 441.00 Mn |
| Dec 31, 2023 | 441.00 Mn |